摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6S,6aS,8R,9S,10aS)-2,4-dimethyl-8-nitro-6,9-diphenyl-6a,7,8,9,10,10a-hexahydro-6H-isochromeno[3,4-d]pyrimidine-1,3-dione | 1353777-87-3

中文名称
——
中文别名
——
英文名称
(6S,6aS,8R,9S,10aS)-2,4-dimethyl-8-nitro-6,9-diphenyl-6a,7,8,9,10,10a-hexahydro-6H-isochromeno[3,4-d]pyrimidine-1,3-dione
英文别名
——
(6S,6aS,8R,9S,10aS)-2,4-dimethyl-8-nitro-6,9-diphenyl-6a,7,8,9,10,10a-hexahydro-6H-isochromeno[3,4-d]pyrimidine-1,3-dione化学式
CAS
1353777-87-3
化学式
C25H25N3O5
mdl
——
分子量
447.491
InChiKey
GZNMFLAIZNUKFE-YIUJWAEMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    33
  • 可旋转键数:
    2
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    95.7
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    (6S,6aS,8R,9S,10aS)-2,4-dimethyl-8-nitro-6,9-diphenyl-6a,7,8,9,10,10a-hexahydro-6H-isochromeno[3,4-d]pyrimidine-1,3-dione二异丁基氢化铝 作用下, 以 四氢呋喃环己烷 为溶剂, 反应 2.0h, 以70%的产率得到(6S,6aS,8R,9S,10aS)-2,4-dimethyl-8-nitro-6,9-diphenyl-3,6,6a,7,8,9,10,10a-octahydroisochromeno[3,4-d]pyrimidin-1-one
    参考文献:
    名称:
    有机催化Michael–Knoevenagel–Hetero-Diels–Alder反应:异异戊二烯嘧啶嘧啶二酮衍生物的高效不对称一锅策略
    摘要:
    通过一锅式迈克尔-克诺伊马格尔缩合-反电子需求的杂-狄尔斯-α,β-不饱和醛,烯属硝基链烷和1,3-二甲基巴比妥酸的一锅反应,已经完成了具有五个立体中心的异戊二烯嘧啶二酮衍生物的合成。通过一锅策略具有出色的非对映异构和对映异构选择性(高达99%ee)。通过X射线分析确认了产物的结构和绝对构型。
    DOI:
    10.1021/ol202877m
  • 作为产物:
    描述:
    1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 氯仿 为溶剂, 反应 6.0h, 以36 mg的产率得到(6S,6aS,8R,9S,10aS)-2,4-dimethyl-8-nitro-6,9-diphenyl-6a,7,8,9,10,10a-hexahydro-6H-isochromeno[3,4-d]pyrimidine-1,3-dione
    参考文献:
    名称:
    有机催化Michael–Knoevenagel–Hetero-Diels–Alder反应:异异戊二烯嘧啶嘧啶二酮衍生物的高效不对称一锅策略
    摘要:
    通过一锅式迈克尔-克诺伊马格尔缩合-反电子需求的杂-狄尔斯-α,β-不饱和醛,烯属硝基链烷和1,3-二甲基巴比妥酸的一锅反应,已经完成了具有五个立体中心的异戊二烯嘧啶二酮衍生物的合成。通过一锅策略具有出色的非对映异构和对映异构选择性(高达99%ee)。通过X射线分析确认了产物的结构和绝对构型。
    DOI:
    10.1021/ol202877m
点击查看最新优质反应信息

文献信息

  • Organocatalytic Michael–Knoevenagel–Hetero-Diels–Alder Reactions: An Efficient Asymmetric One-Pot Strategy to Isochromene Pyrimidinedione Derivatives
    作者:Bor-Cherng Hong、Nitin S. Dange、Chun-Feng Ding、Ju-Hsiou Liao
    DOI:10.1021/ol202877m
    日期:2012.1.20
    Synthesis of isochromene pyrimidinedione derivatives having five stereocenters has been achieved by a one-pot Michael–Knoevenagel condensation–inverse-electron-demand hetero-Diels–Alder reaction of α, β-unsaturated aldehydes, olefinic nitroalkanes, and 1,3-dimethylbarbituric acid via a one-pot strategy with excellent diastereo- and enantioselectivities (up to 99% ee). The structures and absolute configurations
    通过一锅式迈克尔-克诺伊马格尔缩合-反电子需求的杂-狄尔斯-α,β-不饱和醛,烯属硝基链烷和1,3-二甲基巴比妥酸的一锅反应,已经完成了具有五个立体中心的异戊二烯嘧啶二酮衍生物的合成。通过一锅策略具有出色的非对映异构和对映异构选择性(高达99%ee)。通过X射线分析确认了产物的结构和绝对构型。
查看更多

同类化合物

乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 4-(4-methoxyaniline)-5-(phenyl)-8,9-dihydro-5H-chromeno[2,3-d]pyrimidin-6(7H)-one 4-cyclohexyl-2-phenyl-7,8-dihydro-6H-pyranol[3,2-d]pyrimidine 1,3-Bis(p-tolyl)-5-(2'-hydroxyphenyl)-7-methyl-4-oxo-1,2,3,4-tetrahydro-2-thioxo-5H-pyrano<2,3-d>pyrimidine 7,8-dihydro-3H-pyrano[4,3-d]pyrimidin-4(5H)-one 7-amino-2,3,4,5-tetrahydro-5-(3-hydroxyphenyl)-1,3-dimethyl-2,4-dioxo-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile 3-benzyl-6,6,9-trimethyl-6a,7,8,9,10,10a-hexahydro-6H-isochromeno[3,4-d]pyrimidin-1-ol 7'-amino-1-ethyl-2,4'-dioxo-2'-thioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d] pyrimidine]-6'-carbonitrile 7'-amino-2,4'-dioxo-2'-thioxo-1',2',3',4'-tetrahydro-2H-spiro[acenaphthylene-1,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile (3-(((2-(4-(but-2-ynamido)-2-methyl-1H-indol-1-yl)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl)amino)methyl)phenyl)boronic acid 7-amino-5-(2,3-dimethoxyphenyl)-1,3-dimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile 7'-amino-5-chloro-1',3'-dimethyl-2,2',4'-trioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile 7-amino-5-(4-bromophenyl)-1,3-dimethyl-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile 7-amino-5-(4-methoxyphenyl)-1,3-dimethyl-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]-pyrimidine-6-carbonitrile 7,8-dihydro-5H-pyrano[4,3-d]pyrimidine ethyl 2,8-dimethyl-10-phenyl-10H-pyrano[3,2-e][1,2,4]triazolo[1,5-c] pyrimidine-9-carboxylate ethyl 10-(4-methoxyphenyl)-2,8-dimethyl-10H-pyrano[3,2-e][1,2,4]triazolo[1,5-c] pyrimidine-9-carboxylate ethyl 3-{[3-(4-methoxyphenyl)isoxazol-5-yl]methyl}-2,7-dimethyl-4-oxo-5-(p-tolyl)-3,5-dihydro-4H-pyrano[2,3-d]pyrimidine-6-carboxylate 2-thioxo-2,3,7,8-tetrahydro-1H-pyrano[4.3-d]pyrimidin-4(5H)-one 7-amino-2,4-dioxo-5-(m-tolyl)-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile Ethyl 7-amino-5-(4-hydroxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carboxylate 7-amino-5-(3-chlorophenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile 7-amino-5-(2,4-di-chlorophenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile 7-amino-5-(4-(dimethylamino)phenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile Ethyl 7-amino-5-(3,4-dimethoxyphenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate 7-amino-5-(3,4-dimethoxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile ethyl-7-amino-5-(3-nitrphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carboxylate Ethyl 7-amino-5-(4-nitrophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate Ethyl 7-amino-5-(4-methylphenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylate 7'-amino-5-chloro-2,2',4'-trioxo-1',2',3',4'-tetrahydrospiro[indoline-3,5'-pyrano[2,3-d]pyrimidine]-6'-carbonitrile 4-tert-butyl-2-phenyl-7,8-dihydro-6H-pyranol[3,2-d]pyrimidine 6-benzamido-2,3-dihydro-5-methyl-1,3-di(p-chlorophenyl)-2-thioxo-4H-pyrano[2,3-d]pyrimidine-4,7(1H)-dione 6-benzamido-2,3-dihydro-5-methyl-1,3-diphenyl-2-thioxo-4H-pyrano[2,3-d]pyrimidine-4,7(1H)-dione 4-phenylhexahydro-1H-pyrano[2,3-d]pyrimidin-2(8aH)-one 4-(4-methoxyphenyl)hexahydro-1H-pyrano[2,3-d]pyrimidin-2(8aH)-one 7-amino-1,3-dimethyl-2,4-dioxo-5-phenyl-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile 7'‑amino‑2,4′‑dioxo‑2′‑thioxo‑1′,2′,3′,4′‑tetrahydrospiro[indoline‑3,5'‑pyrano[2,3‑d]pyrimidine]‑6'‑carbonitrile 7-Amino-5-(1H-indol-3-yl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d] pyrimidine-6-carbonitrile methyl 2-amino-5,7-dioxospiro[1'-methyl-3'H-indol-3',4-4H-5,6,7,8-tetrahydropyrano[2,3-d]pyramidine]-1'H-2'-one-3-carboxylate 7-benzyl-7-methyl-4-phenyl-3,4,7,8-tetrahydro-1H-pyrano[4,3-d]pyrimidine-2,5-dione 7,7-dimethyl-4-phenyl-2-thioxo-1,2,3,4,7,8-hexahydro-pyrano[4,3-d]pyrimidin-5-one